Use and validation of HT/HC assays to support 21st century toxicity evaluations. (Q50882459)

24 March 2018

title

Use and validation of HT/HC assays to support 21st century toxicity evaluations. (English)

1 reference

24 March 2018

author

Grace Patlewicz

1

1 reference

24 March 2018

Ted Simon

object named as

Ted Simon

2

0 references

Katy Goyak

object named as

Katy Goyak

3

0 references

author name string

Richard D Phillips

4

1 reference

24 March 2018

J Craig Rowlands

5

1 reference

24 March 2018

Shawn D Seidel

6

1 reference

24 March 2018

Richard A Becker

7

1 reference

24 March 2018

language of work or name

English

0 references

publication date

3 January 2013

1 reference

24 March 2018

Regulatory Toxicology and Pharmacology

published in

1 reference

24 March 2018

volume

65

1 reference

24 March 2018

issue

2

1 reference

24 March 2018

page(s)

259-268

1 reference

24 March 2018

Relationship between the results of in vitro receptor binding assay to human estrogen receptor alpha and in vivo uterotrophic assay: comparative study with 65 selected chemicals.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

The principles of weight of evidence validation of test methods and testing strategies. The report and recommendations of ECVAM workshop 58.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Application of key events analysis to chemical carcinogens and noncarcinogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

The Cochrane collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Systematic Reviews: Reporting, updating, and correcting systematic reviews of the effects of health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Framework for use of toxicity screening tools in context-based decision-making

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Changes in DNA repair during aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Hallmarks of Cancer: The Next Generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Food for Thought ... on mapping the human toxome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Critical evaluation of key evidence on the human health hazards of exposure to bisphenol A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

In vitro screening of environmental chemicals for targeted testing prioritization: the ToxCast project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

The Key Events Dose-Response Framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Identification and characterization of adverse effects in 21st century toxicology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

A theoretical framework for gene induction and experimental comparisons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

DNA replication fidelity and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Endocrine profiling and prioritization of environmental chemicals using ToxCast data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Overview: Using mode of action and life stage information to evaluate the human relevance of animal toxicity data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Dose-dependent transitions in mechanisms of toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

A biomonitoring framework to support exposure and risk assessments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Accelerating the development of 21st-century toxicology: outcome of a Human Toxicology Project Consortium workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Evidence-based toxicology for the 21st century: opportunities and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods†

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2012.12.008

10.1016/J.YRTPH.2012.12.008

7 January 2021

Identifiers

DOI

1 reference

24 March 2018

PubMed ID

23291301

1 reference

24 March 2018